Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Fan

Showing results (1271-1280 of 1,288) with videos related to

Pageof 129
Sort By:
Science (New York, N.Y.)|January 26, 2023
Human impacts outpace natural processes in the AmazonJames S Albert, Ana C Carnaval, Suzette G A Flantua, et al.
Clinical Kidney Journal|October 8, 2025
Age at disease onset and risk of chronic kidney disease in patients with heterozygous disease-causing variants in <i>COL4A3</i> and <i>COL4A4</i>Ningning Hu, Lei Sun, Xuantong Dai, et al.
International Journal of Cancer|December 7, 2020
Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screeningGeng-Hang Chen, Zhiwei Liu, Ming-Fang Ji, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Clinical Chemistry|March 24, 2022
Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening ProgramsGeng Hang Chen, Zhiwei Liu, Kelly J Yu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Acta Neuropathologica|June 14, 2021
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsYing Fan, Raja S Nirujogi, Alicia Garrido, et al.
The New Phytologist|July 1, 2021
An integrated framework of plant form and function: the belowground perspectiveAlexandra Weigelt, Liesje Mommer, Karl Andraczek, et al.
The Oncologist|February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid TumorsSarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Pageof 129

Showing results (1271-1280 of 1,288) with videos related to

Sort By:
Pageof 129
Science (New York, N.Y.)|January 26, 2023
Human impacts outpace natural processes in the AmazonJames S Albert, Ana C Carnaval, Suzette G A Flantua, et al.
Clinical Kidney Journal|October 8, 2025
Age at disease onset and risk of chronic kidney disease in patients with heterozygous disease-causing variants in <i>COL4A3</i> and <i>COL4A4</i>Ningning Hu, Lei Sun, Xuantong Dai, et al.
International Journal of Cancer|December 7, 2020
Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screeningGeng-Hang Chen, Zhiwei Liu, Ming-Fang Ji, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Clinical Chemistry|March 24, 2022
Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening ProgramsGeng Hang Chen, Zhiwei Liu, Kelly J Yu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Acta Neuropathologica|June 14, 2021
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophilsYing Fan, Raja S Nirujogi, Alicia Garrido, et al.
The New Phytologist|July 1, 2021
An integrated framework of plant form and function: the belowground perspectiveAlexandra Weigelt, Liesje Mommer, Karl Andraczek, et al.
The Oncologist|February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid TumorsSarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Pageof 129